0.75% Phentolamine Ophthalmic Solution for vitamin a deficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Aug 2025: Trial registered, NCT07140783
  2. 2 Sep 2025: Trial started, NCT07140783

The trials

NCT07140783: OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

State
Under way
Phase
Phase 3
People
580 planned
Started
2 Sep 2025
Primary completion
Aug 2027
Arms
0.75% Phentolamine Ophthalmic Solution
Results
None posted
  1. 26 Aug 2025: Trial registered
  2. 2 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.